First Time Loading...

Viatris Inc
NASDAQ:VTRS

Watchlist Manager
Viatris Inc Logo
Viatris Inc
NASDAQ:VTRS
Watchlist
Price: 11.94 USD 0.93% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. [ Read More ]

The intrinsic value of one VTRS stock under the Base Case scenario is 32.08 USD. Compared to the current market price of 11.94 USD, Viatris Inc is Undervalued by 63%.

Key Points:
VTRS Intrinsic Value
Base Case
32.08 USD
Undervaluation 63%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Viatris Inc

Backtest VTRS Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VTRS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Viatris Inc's business.

What risks and challenges
does Viatris Inc face in the near future?

Summarize the latest earnings report
of Viatris Inc.

Provide P/E
for Viatris Inc and its competitors.

Financials

Balance Sheet Decomposition
Viatris Inc

Current Assets 13B
Cash & Short-Term Investments 1.1B
Receivables 3.7B
Other Current Assets 8.2B
Non-Current Assets 34.7B
Long-Term Investments 165.7m
PP&E 3B
Intangibles 29B
Other Non-Current Assets 2.5B
Current Liabilities 7.8B
Accounts Payable 1.4B
Accrued Liabilities 2.3B
Other Current Liabilities 4.1B
Non-Current Liabilities 19.4B
Long-Term Debt 16.2B
Other Non-Current Liabilities 3.3B
Efficiency

Earnings Waterfall
Viatris Inc

Revenue
15.4B USD
Cost of Revenue
-8.7B USD
Gross Profit
6.7B USD
Operating Expenses
-5.1B USD
Operating Income
1.6B USD
Other Expenses
-1.5B USD
Net Income
54.7m USD

Free Cash Flow Analysis
Viatris Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

VTRS Profitability Score
Profitability Due Diligence

Viatris Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
ROE is Increasing
49/100
Profitability
Score

Viatris Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

VTRS Solvency Score
Solvency Due Diligence

Viatris Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Low D/E
Low Altman Z-Score
33/100
Solvency
Score

Viatris Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VTRS Price Targets Summary
Viatris Inc

Wall Street analysts forecast VTRS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTRS is 12.09 USD with a low forecast of 10.1 USD and a high forecast of 14.7 USD.

Lowest
Price Target
10.1 USD
15% Downside
Average
Price Target
12.09 USD
1% Upside
Highest
Price Target
14.7 USD
23% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

VTRS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

VTRS Price
Viatris Inc

1M 1M
-3%
6M 6M
+21%
1Y 1Y
+27%
3Y 3Y
-9%
5Y 5Y
-54%
10Y 10Y
-73%
Annual Price Range
11.94
52w Low
8.77
52w High
13.53
Price Metrics
Average Annual Return -18.87%
Standard Deviation of Annual Returns 7.2%
Max Drawdown -69%
Shares Statistics
Market Capitalization 14.3B USD
Shares Outstanding 1 187 570 000
Percentage of Shares Shorted 4.11%

VTRS Return Decomposition
Main factors of price return

What is price return decomposition?

VTRS News

Other Videos

Last Important Events
Viatris Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Viatris Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Viatris Inc Logo
Viatris Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

14.3B USD

Dividend Yield

4.06%

Description

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. The company is headquartered in Canonsburg, Pennsylvania and currently employs 37,000 full-time employees. The firm has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The company operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Contact

PENNSYLVANIA
Canonsburg
1000 Mylan Boulevard
+17245141465.0
https://www.viatris.com/en

IPO

1973-02-01

Employees

37 000

Officers

CEO & Director
Mr. Scott Andrew Smith
President & Executive Director
Mr. Rajiv Malik
Chief Financial Officer
Mr. Sanjeev Narula
President of Developed Markets
Mr. Anthony Mauro
Chief Operating Officer
Mr. Sanjeev Kumar Sethi
Chief Accounting Officer, Senior VP & Corporate Controller
Mr. Paul B. Campbell
Show More
Global General Counsel
Mr. Brian S. Roman
Chief Compliance Officer
Mr. David Bayles
Head of Global Communications & Corporate Brand
Ms. Jennifer Mauer
Chief Human Relations Officer
Mr. Andrew Enrietti
Show Less

See Also

Discover More
What is the Intrinsic Value of one VTRS stock?

The intrinsic value of one VTRS stock under the Base Case scenario is 32.08 USD.

Is VTRS stock undervalued or overvalued?

Compared to the current market price of 11.94 USD, Viatris Inc is Undervalued by 63%.